pulseData Raises $16.5M from Bain Capital Private Equity and Two Bear Capital
Learn More
GET A DEMO
helping you deliver precise care at less cost
Slowing chronic disease takes more than just computing models. We work with you from data to care delivery to ensure insights are trusted and actionable.
Find undiagnosed and unaware disease sufferers
Drive precise interventions to eliminate bad events
Get better outcomes and cost savings
Find Undiagnosed and Unaware Disease Sufferers
Drive Precise Interventions to Eliminate Bad Events
Get Better Outcomes and Cost Savings
Contact us for A DEMO
Employer plans

We give you visibility into the impact and cost of kidney care at your company.

Identify undiagnosed patients with kidney disease and track their care to improve health outcomes and avoid large, unpredictable medical bills.

Learn more →
Payers

We understand the basic business of kidney care is being transformed.

Minimize the cost of care by knowing which members are high-risk and driving early intervention.

Learn more →
Kidney care providers

We do the data, you deliver the care.

Succeed in this shifting space by deploying precisely-targeted care delivery to the patients who need it most.  

"We see the partnership between Rogosin and pulseData as critical to our future. We believe the current CKD project is the beginning of many collaborative projects to come and we look forward to the continued growth and success of our relationship."

— Dr. Jeffrey Silberzweig, Chief Medical Officer of The Rogosin Institute

Learn more →
Value-based systems

We know who is at-risk.

We partner closely with your providers to reduce the burden of chronic disease across your population by letting them know exactly who is at risk of acute events and which of their care workflows are working.

Learn more →
Vytalize Health Innovation Lab selects pulseData's AI-Powered Platform for Chronic Kidney Disease
May 26, 2021

Using pulseData’s risk stratification tool, Vytalize Health is helping its primary care practices identify Medicare patients at risk of bad events, triage care, and allocate limited resources.

pulseData’s recent patent award provides essential component to solve chronic illness
May 18, 2021

Today, pulseData announces that it was awarded a U.S. patent for a machine learning technology which detects the risk of renal decline, validating that there are repeatable, provable methods for predicting acute events. The implications of this technology are dramatic for the 37 million Americans that suffer from Chronic Kidney Disease (CKD).

pulseData Raises $16.5 Million in Series A Funding Led by Bain Capital Private Equity and Two Bear Capital
April 21, 2021

pulseData, a New York City-based healthcare data science company, focused on predictive algorithms for Chronic Kidney Disease and other chronic diseases, today announced $16.5 million in Series A funding led by Bain Capital Private Equity and Two Bear Capital, with participation from Alumni Ventures Group and existing investors.

Partners

These value-based care teams use pulseData software and prediction engines
Learn more about our collaborative approach →

Subscribe our posts

Thanks! Your subscription has been confirmed!
Oops! Something went wrong while submitting the form.
Close